15. Determine the profitability of each product after allocating joint costs using their net realizable value, if the byproduct is accounted for at the time of sale.Engelbert Pharmaceuticals produces two drugs in a joint process that also results in a byproduct.

The joint process costs $108,000, and results in three chemicals—10,000 grams of Chemical AZBP, which could sell at splitoff for $2 per gram, 20,000 grams of Chemical RQFN, which could sell at splitoff for $1.50 per gram, and 50,000 grams of Chemical LRZS, which sells at splitoff for $0.02 per gram. AZBP is processed into the drug Meozin at an additional cost of

$40,000. Each pill requires 20 milligrams of AZBP, and sells for $0.50 each. RQFN is processed into the drug Clopine at an additional cost of $150,000. Each pill requires 10 milligrams of RQFN, and sells for $0.10 each.